Colon Cancer Symptoms - New Eloxatin (oxaliplatin injection) Prescribing Information in the U - Phramalive.com
New Eloxatin (oxaliplatin injection) Prescribing Information in the U - Phramalive.com
- FDA Approval Based on Updated Results Showing a 20% Reduction in the Risk of Death at Six Years and a 22% Improvement of Disease Free Survival at Five Years, For Stage III Colon Cancer, Post Surgery - BRIDGEWATER, N.J., May 28, 2008 /PRNewswire
Study may show Erbitux helps lung cancer patients - Houston Chronicle
ImClone Systems’ only drug, Erbitux, may extend life for lung cancer patients in a study scheduled for release next week. The findings may not help ImClone shares. Between August and May, ImClone rose 60 percent as investors bet Erbitux will be
Imclone’s Trading Signals Failure to Beat Avastin (Update3) - Bloomberg
May 28 (Bloomberg) — ImClone Systems Inc. ’s only drug, Erbitux, may extend life for lung cancer patients in a study scheduled for release next week. The findings may not help ImClone shares. Between August and May , ImClone rose 60 percent as
Gene Mutation May Shift Cancer Treatment, Erbitux Use - CNN Money
NEW YORK -(Dow Jones)- KRAS may look like the call letters of a radio station, but it’s increasingly becoming the place where doctors look to determine treatment options for certain cancers. KRAS - pronounced Kay-rass - is a gene that mutates in some